| Mrs Amanda J Dolif, APRN | |
|
11011 Sheridan St Ste 109, Hollywood, FL 33026-1501 | |
| (954) 961-8400 | |
| (954) 961-8401 |
| Full Name | Mrs Amanda J Dolif |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 11011 Sheridan St Ste 109, Hollywood, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033773890 | NPI | - | NPPES |
| APRN11002252 | Other | FL | APRN |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2100X | Nurse Practitioner - Acute Care | 11002252 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Boca Raton Regional Hospital | Boca raton, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gastro Health, Llc | 2365440567 | 236 |
News Archive
Ghana's minister of justice and attorney general, Betty Mould-Iddrisu, recently called on private and public employers to create policies that would provide comprehensive care to employees living with HIV or tuberculosis, as well as their families, GNA/GhanaWeb.com reports.
Scientists at The Scripps Research Institute have discovered a potential new use for the drug closantel, currently the standard treatment for sheep and cattle infected with liver fluke. The new research suggests that the drug may be useful in combating river blindness, a tropical disease that is the world's second leading infectious cause of blindness for humans.
IntegraGen, Inc., a biotechnology company dedicated to molecular biomarker discovery, today announced the launch of the ARISk- Risk Assessment Test, a gender specific, genetic screening test that looks at 65 genetic markers associated with Autism Spectrum Disorder.
Impax Laboratories, Inc. today confirmed that the U.S. Food and Drug Administration (FDA) has granted tentative approval of the Company's Abbreviated New Drug Application (ANDA) for generic version of FLOMAX® (tamsulosin hydrochloride) 0.4mg capsules. Boehringer Ingelheim Pharmaceuticals, Inc. markets FLOMAX® for the functional symptoms of benign prostatic hyperplasia.
Whole body vibration appears to improve many symptoms of type II diabetes mellitus, wherein glucose and destructive inflammation shoots up. The procedure helps the body use glucose as an energy source, and at the same time, modify the microbiome to fight inflammation, a new study says.
› Verified 5 days ago
| Entity Name | Gastro Health, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487767133 PECOS PAC ID: 2365440567 Enrollment ID: O20061127000011 |
News Archive
Ghana's minister of justice and attorney general, Betty Mould-Iddrisu, recently called on private and public employers to create policies that would provide comprehensive care to employees living with HIV or tuberculosis, as well as their families, GNA/GhanaWeb.com reports.
Scientists at The Scripps Research Institute have discovered a potential new use for the drug closantel, currently the standard treatment for sheep and cattle infected with liver fluke. The new research suggests that the drug may be useful in combating river blindness, a tropical disease that is the world's second leading infectious cause of blindness for humans.
IntegraGen, Inc., a biotechnology company dedicated to molecular biomarker discovery, today announced the launch of the ARISk- Risk Assessment Test, a gender specific, genetic screening test that looks at 65 genetic markers associated with Autism Spectrum Disorder.
Impax Laboratories, Inc. today confirmed that the U.S. Food and Drug Administration (FDA) has granted tentative approval of the Company's Abbreviated New Drug Application (ANDA) for generic version of FLOMAX® (tamsulosin hydrochloride) 0.4mg capsules. Boehringer Ingelheim Pharmaceuticals, Inc. markets FLOMAX® for the functional symptoms of benign prostatic hyperplasia.
Whole body vibration appears to improve many symptoms of type II diabetes mellitus, wherein glucose and destructive inflammation shoots up. The procedure helps the body use glucose as an energy source, and at the same time, modify the microbiome to fight inflammation, a new study says.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Amanda J Dolif, APRN 9500 S Dadeland Blvd Ste 200, Miami, FL 33156-2866 Ph: (305) 468-4185 | Mrs Amanda J Dolif, APRN 11011 Sheridan St Ste 109, Hollywood, FL 33026-1501 Ph: (954) 961-8400 |
News Archive
Ghana's minister of justice and attorney general, Betty Mould-Iddrisu, recently called on private and public employers to create policies that would provide comprehensive care to employees living with HIV or tuberculosis, as well as their families, GNA/GhanaWeb.com reports.
Scientists at The Scripps Research Institute have discovered a potential new use for the drug closantel, currently the standard treatment for sheep and cattle infected with liver fluke. The new research suggests that the drug may be useful in combating river blindness, a tropical disease that is the world's second leading infectious cause of blindness for humans.
IntegraGen, Inc., a biotechnology company dedicated to molecular biomarker discovery, today announced the launch of the ARISk- Risk Assessment Test, a gender specific, genetic screening test that looks at 65 genetic markers associated with Autism Spectrum Disorder.
Impax Laboratories, Inc. today confirmed that the U.S. Food and Drug Administration (FDA) has granted tentative approval of the Company's Abbreviated New Drug Application (ANDA) for generic version of FLOMAX® (tamsulosin hydrochloride) 0.4mg capsules. Boehringer Ingelheim Pharmaceuticals, Inc. markets FLOMAX® for the functional symptoms of benign prostatic hyperplasia.
Whole body vibration appears to improve many symptoms of type II diabetes mellitus, wherein glucose and destructive inflammation shoots up. The procedure helps the body use glucose as an energy source, and at the same time, modify the microbiome to fight inflammation, a new study says.
› Verified 5 days ago
Fiorella Jahaira Saka, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1150 N 35th Ave, Suite 590, Hollywood, FL 33021 Phone: 954-265-9500 Fax: 954-265-1431 | |
Bella Gleiser Mendez, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1150 N 35th Ave Ste 385, Hollywood, FL 33021 Phone: 954-265-4325 | |
Andrea Annmarie Goulbourne-smith, APRN, PMHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 7369 Sheridan St Ste 101, Hollywood, FL 33024 Phone: 954-561-6222 Fax: 954-990-7650 | |
Roberto Santamaria, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1957 Jackson St, Hollywood, FL 33020 Phone: 954-921-2600 | |
Jennifer Aphrodite Germain, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1920 N 53rd Ave, Hollywood, FL 33021 Phone: 305-450-8698 | |
Linda C Barreras, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 750 S Federal Hwy, Hollywood, FL 33020 Phone: 954-342-8800 Fax: 954-342-8700 | |
Mrs. Christine M Browne, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 200 S Park Rd Ste 200, Hollywood, FL 33021 Phone: 954-923-7440 Fax: 954-923-1299 |